NEW YORK ( TheStreet) -- Sequenom (Nasdaq: SQNM) hit a new 52-week low Monday as it is currently trading at $3.98, below its previous 52-week low of $4 with 2.3 million shares traded as of 2 p.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Sequenom has a market cap of $416.2 million and is part of the health care sector and drugs industry. Shares are down 48.1% year to date as of the close of trading on Friday.

Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research.

TheStreet Ratings rates Sequenom as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full Sequenom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.